4,919 results match your criteria: "Institute of Medical Genetics[Affiliation]"
J Natl Cancer Inst
December 2024
Hereditary Research Laboratory, Bethlehem University, Bethlehem, Palestine.
Pathogenic TP53 germline variants cause young-onset breast cancer and other cancers of the Li-Fraumeni syndrome (LFS) spectrum, but the clinical consequences of partial-loss-of function TP53 variants are incompletely understood. In the consecutive cohort of Palestinian breast cancer patients of the Middle East Breast Cancer Study (MEBCS), breast cancer risk among TP53 p. R181C heterozygotes was 50% by age 50 y and 81% by age 80 y.
View Article and Find Full Text PDFClin Transl Radiat Oncol
January 2025
Institute of Medical Genetics and Applied Genomics, Medical Faculty and University Hospital, Tübingen, Germany.
Background And Purpose: Neoadjuvant chemoradiotherapy (NCRT) is a standard treatment option for locally advanced rectal cancer. However, there is still conflicting data about the genetic landscape and potential dynamics during and after NCRT. This study evaluated oncogenic driver mutations before NCRT and investigated corresponding resection samples after treatment.
View Article and Find Full Text PDFEur J Hum Genet
December 2024
Department of Human Genetics, Inselspital Bern, University of Bern, Bern, Switzerland.
While mostly de novo truncating variants in SCAF4 were recently identified in 18 individuals with variable neurodevelopmental phenotypes, knowledge on the molecular and clinical spectrum is still limited. We assembled data on 50 novel individuals with SCAF4 variants ascertained via GeneMatcher and personal communication. With detailed evaluation of clinical data, in silico predictions and structural modeling, we further characterized the molecular and clinical spectrum of the autosomal dominant SCAF4-associated neurodevelopmental disorder.
View Article and Find Full Text PDFBrain
December 2024
Institute of Medical Genetics and Applied Genomics, University of Tübingen, 72076 Tübingen, Germany.
Clin Sci (Lond)
December 2024
Institute for Medical Virology, Department of Molecular Virology, University Hospital Tuebingen,, Tübingen, Germany.
Indian Pediatr
December 2024
Senior Consultant and Vice Chairperson, Institute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi
NAR Genom Bioinform
December 2024
The Robinson Lab, The Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, 06032, Connecticut, USA.
Hi-C and capture Hi-C (CHi-C) both leverage paired-end sequencing of chimeric fragments to gauge the strength of interactions based on the total number of paired-end reads mapped to a common pair of restriction fragments. Mapped paired-end reads can have four relative orientations, depending on the genomic positions and strands of the two reads. We assigned one paired-end read orientation to each of the four possible re-ligations that can occur between two given restriction fragments.
View Article and Find Full Text PDFEur J Hum Genet
December 2024
Neuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
PeerJ
December 2024
Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
Background: Chronic lymphocytic leukemia (CLL) is a common adult leukemia characterized by the accumulation of neoplastic mature B cells in blood, bone marrow, lymph nodes, and spleen. The disease biology remains unresolved in many aspects, including the processes underlying the disease progression and relapses. However, studying CLL poses a considerable challenge due to its complexity and dependency on the microenvironment.
View Article and Find Full Text PDFNat Biotechnol
December 2024
Department of Surgery, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Dermatol Pract Concept
October 2024
Department of Dermatology, University Hospital of Basel, Basel, Switzerland.
Am J Med Genet A
December 2024
Institute for Maternal and Child Health, IRCCS "Burlo Garofolo", Trieste, Italy.
Alteration in the ubiquitin-proteasome system results in human disorders with neurological and/or autoinflammatory presentation. Haploinsufficiency of PSMD12, which encodes a subunit of the core component of the proteasome, causes Stankiewicz-Isidor syndrome (STISS), characterized by intellectual disability, autism spectrum disorder, craniofacial dysmorphisms, with or without other congenital anomalies, and autoinflammation. We described six patients (four adults) from two unrelated families carrying a known p.
View Article and Find Full Text PDFGenet Med
January 2025
School of Health, University of the Sunshine Coast, Maroochydore, QLD, Australia; National PTSD Research Centre, Thompson Institute, Birtinya, QLD, Australia. Electronic address:
Mol Syndromol
December 2024
Institute of Medical Genetics and Genomics Ganga Ram Institute of Post Graduate Medical Education and Research Sir Ganga Ram Hospital, New Delhi, India.
Cell Oncol (Dordr)
December 2024
Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, 625 00, Czech Republic.
Purpose: Pediatric sarcomas are bone and soft tissue tumors that often exhibit high metastatic potential and refractory stem-like phenotypes, resulting in poor outcomes. Aggressive sarcomas frequently harbor a disrupted p53 pathway. However, whether pediatric sarcoma stemness is associated with abrogated p53 function and might be attenuated via p53 reactivation remains unclear.
View Article and Find Full Text PDFInt J Gynaecol Obstet
December 2024
Department of Medical Biology and Genetics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Genome Biol
December 2024
Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, 72076, Germany.
Background: Atypical teratoid rhabdoid tumors (ATRT) are incurable high-grade pediatric brain tumors. Despite intensive research efforts, the prognosis for ATRT patients under currently established treatment protocols is poor. While novel therapeutic strategies are urgently needed, the generation of molecular-driven treatment concepts is a challenge mainly due to the absence of actionable genetic alterations.
View Article and Find Full Text PDFFront Neurosci
November 2024
Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Mol Cells
January 2025
Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Gustav Wieds Vej 14, 8000 Aarhus Centrum, Denmark; Department of Molecular Biology and Genetics, Aarhus University, Universitetsbyen 81, 8000 Aarhus Centrum, Denmark. Electronic address:
The clinical manifestations of Parkinson's disease (PD) are driven by aggregation of α-Synuclein (α-Syn) in the brain. However, there is increasing evidence that PD may be initiated in the gut and thence spread to the brain, eg, via the vagus nerve. Many studies link PD to changes in the gut microbiome, and bacterial amyloid has been shown to stimulate α-Syn aggregation.
View Article and Find Full Text PDFJAMA Dermatol
January 2025
Department of Dermatology, University Hospital of Basel, Basel, Switzerland.
J Natl Cancer Inst
November 2024
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Comput Struct Biotechnol J
December 2024
Department of Pathology and Molecular Pathology, University Hospital and University of Zürich, Zürich, Switzerland.
J Thorac Oncol
November 2024
Royal Prince Alfred Hospital, NSW Health Pathology, Camperdown, New South Wales, Australia.
Introduction: With the implementation of low-dose computed tomography screening, multiple pulmonary tumor nodules are diagnosed with increasing frequency and the selection of surgical treatments versus systemic therapies has become challenging on a daily basis in clinical practice. In the presence of multiple carcinomas, especially adenocarcinomas, pathologically determined to be of pulmonary origin, the distinction between separate primary lung carcinomas (SPLCs) and intrapulmonary metastases (IPMs) is important for staging, management, and prognostication.
Methods: We systemically reviewed various means that aid in the differentiation between SPLCs and IPMs explored by histopathologic evaluation and molecular profiling, the latter includes DNA microsatellite analysis, array comparative genomic hybridization, TP53 and oncogenic driver mutation testing and, more recently, with promising effectiveness, next-generation sequencing comprising small- or large-scale multi-gene panels.
Front Med (Lausanne)
November 2024
Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Brain Commun
November 2024
CHU Sainte-Justine Azrieli Research Centre, Montreal H3T 1C5, Canada.
Hydrocephalus and Dandy-Walker malformation are amongst the most common congenital brain anomalies. We identified three consanguineous families with both obstructive hydrocephalus and Dandy-Walker malformation. To understand the molecular basis of these anomalies, we conducted genome-wide sequencing in these families.
View Article and Find Full Text PDF